A kind of separation and purification method of doramectin
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- CHONGQING QIANTAI BIOLOGICAL MEDICINE
- Publication Date
- 2018-03-27
Smart Images

Figure 1 
Figure 2
Abstract
Description
technical field
[0001] The invention belongs to the field of medicinal chemistry, and in particular relates to a separation and purification method of doramectin. Background technique
[0002] Doramectin (DRM) is the third-generation derivative of the macrolide antibiotic abamectin, produced by Streptomyces avermitilis ( Streptomyces avermitilis ) genetically engineered mutant strains were biosynthesized by adding cyclohexyl carboxylic acid to obtain a sixteen-membered macrolide semi-synthetic antibiotic, and the difference from ivermectin was in C 25 There is a cyclohexyl group in the position. The chemical name is 25-cyclohexyl-5-O-demethyl-25-de(1-methylpropyl) abamectin B1, and its chemical nature belongs to macrolide antibiotics, and its molecular formula is C 50 h 74 o 14 , Molecular weight is 899.11, melting point: 116°C-119°C, high fat solubility, easily soluble in organic solvents, such as methanol, ethanol, acetone, 1,2-propylene glycol, ethyl acetate, dimethyl...